Histologic classification of ductal carcinoma in situ
- 8 October 2002
- journal article
- review article
- Published by Wiley in Microscopy Research and Technique
- Vol. 59 (2) , 92-101
- https://doi.org/10.1002/jemt.10180
Abstract
Prior to the current mammographic era, ductal carcinoma in situ (DCIS) usually presented as a large mass, was classified morphologically by architecture, and treated by mastectomy. The introduction of screening mammography led to an increase in the incidence of DCIS, a decrease in the average size of DCIS, and an increased emphasis on its heterogeneous nature. Thus, a reproducible and prognostically relevant classification system for DCIS is necessary. The ultimate goal of this classification is proper selection of patients for whom lumpectomy would suffice rather than mastectomy. Features to evaluate include: extent and size of disease, adequacy of resection margins, and histology. While none of the proposed histological classification systems were endorsed at the recent Consensus Conference on the Classification of DCIS, nuclear grade was the most important feature common to most of them. Architecture was given secondary importance. By definition, DCIS is a non‐invasive clonal proliferation of epithelial cells originating in the terminal duct lobular unit, which would be expected to be monomorphic; however, it is the degree of nuclear pleomorphism that is primarily used to separate DCIS into low, intermediate, and high grades. Architecturally, DCIS has been divided into the following types: comedo, solid, cribriform, micropapillary, and papillary. Different architectural patterns and grades may be present in a given particular case; however, some combinations of patterns occur more frequently than others. Interobserver studies have shown nuclear grading to be interpreted with greater consistency than architecture, and nuclear grading methods have correlated with biological and molecular marker studies. Microsc. Res. Tech. 59:92–101, 2002.Keywords
This publication has 36 references indexed in Scilit:
- Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853The Lancet, 2000
- A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinomaHistopathology, 1996
- Lumpectomy Compared with Lumpectomy and Radiation Therapy for the Treatment of Intraductal Breast CancerNew England Journal of Medicine, 1993
- Noninvasive ductal carcinoma of the breast: The relevance of histologic categorizationHuman Pathology, 1993
- Spindle-Cell Argyrophilic Mucin-Producing Carcinoma of the Breast Histological, Ultrastructural, and Immunohistochemical Studies of Two CasesThe American Journal of Surgical Pathology, 1991
- Morphometric studies in intraductal breast carcinoma using computerized image analysisCancer, 1991
- Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situHuman Pathology, 1990
- Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrenceCancer, 1989
- A morphological and immunocytochemical study of a distinctive variant of ductal carcinoma in‐situ of the breastHistopathology, 1985
- Duct carcinoma in situ . Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short‐term treatment failuresCancer, 1982